DexCom Inc (DXCM)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 6,484,500 6,353,800 6,799,200 6,482,200 6,264,500 6,596,200 6,820,700 5,515,900 5,391,700 4,899,200 5,217,400 5,057,000 4,863,600 4,775,900 4,503,800 4,389,800 4,290,500 3,833,200 3,521,800 2,447,900
Total stockholders’ equity US$ in thousands 2,102,600 1,979,000 2,434,300 2,246,800 2,068,600 2,267,900 2,100,400 2,233,000 2,131,800 1,824,500 2,255,900 2,189,300 2,251,500 2,136,100 1,997,600 1,903,200 1,826,500 1,499,300 1,353,900 934,500
Financial leverage ratio 3.08 3.21 2.79 2.89 3.03 2.91 3.25 2.47 2.53 2.69 2.31 2.31 2.16 2.24 2.25 2.31 2.35 2.56 2.60 2.62

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $6,484,500K ÷ $2,102,600K
= 3.08

The financial leverage ratio of DexCom Inc has shown fluctuations over the past few years, ranging from 2.16 to 3.25. This ratio measures the extent to which the company relies on debt to finance its operations and growth. A higher financial leverage ratio indicates a higher level of debt relative to equity.

From the data provided, we can observe that DexCom's financial leverage ratio decreased from 2.62 on March 31, 2020, to a low of 2.16 on December 31, 2021. However, the ratio started to increase again in the subsequent periods, reaching 3.25 on June 30, 2023. This increase suggests that the company might have taken on more debt to fund its operations or growth initiatives during that period.

It is important for investors and stakeholders to closely monitor DexCom's financial leverage ratio, as a high ratio could indicate increased financial risk and vulnerability to economic downturns or interest rate fluctuations. Additionally, a high financial leverage ratio may impact the company's ability to access additional financing or affect its creditworthiness in the eyes of lenders and investors.


See also:

DexCom Inc Financial Leverage (Quarterly Data)